Application 021392

Type
NDA
Sponsor
BAUSCH

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CARDIZEM LADILTIAZEM HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL120MGYesNo
002CARDIZEM LADILTIAZEM HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL180MGYesNo
003CARDIZEM LADILTIAZEM HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL240MGYesNo
004CARDIZEM LADILTIAZEM HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL300MGYesNo
005CARDIZEM LADILTIAZEM HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL360MGYesNo
006CARDIZEM LADILTIAZEM HYDROCHLORIDETABLET, EXTENDED RELEASE;ORAL420MGYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021392-001CARDIZEM LADILTIAZEM HYDROCHLORIDE120MGTABLET, EXTENDED RELEASE / ORALABRLD2003-02-06
N021392-002CARDIZEM LADILTIAZEM HYDROCHLORIDE180MGTABLET, EXTENDED RELEASE / ORALABRLD2003-02-06
N021392-003CARDIZEM LADILTIAZEM HYDROCHLORIDE240MGTABLET, EXTENDED RELEASE / ORALABRLD2003-02-06
N021392-004CARDIZEM LADILTIAZEM HYDROCHLORIDE300MGTABLET, EXTENDED RELEASE / ORALABRLD2003-02-06
N021392-005CARDIZEM LADILTIAZEM HYDROCHLORIDE360MGTABLET, EXTENDED RELEASE / ORALABRLD2003-02-06
N021392-006CARDIZEM LADILTIAZEM HYDROCHLORIDE420MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-02-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 6 matching rows.

Application-product, TE code table
Application-productTE code
N021392-001AB
N021392-002AB
N021392-003AB
N021392-004AB
N021392-005AB
N021392-006AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06N021392-001CARDIZEM LA120MGTABLET, EXTENDED RELEASE / ORALABRLD2003-02-06a50c72e98297…
2026-08-01 22:54:322026-06N021392-002CARDIZEM LA180MGTABLET, EXTENDED RELEASE / ORALABRLD2003-02-06a50c72e98297…
2026-08-01 22:54:322026-06N021392-003CARDIZEM LA240MGTABLET, EXTENDED RELEASE / ORALABRLD2003-02-06a50c72e98297…
2026-08-01 22:54:322026-06N021392-004CARDIZEM LA300MGTABLET, EXTENDED RELEASE / ORALABRLD2003-02-06a50c72e98297…
2026-08-01 22:54:322026-06N021392-005CARDIZEM LA360MGTABLET, EXTENDED RELEASE / ORALABRLD2003-02-06a50c72e98297…
2026-08-01 22:54:322026-06N021392-006CARDIZEM LA420MGTABLET, EXTENDED RELEASE / ORALABRLD, RS2003-02-06a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06N021392-001AB1a50c72e98297…
2026-08-01 22:54:322026-06N021392-002AB1a50c72e98297…
2026-08-01 22:54:322026-06N021392-003AB1a50c72e98297…
2026-08-01 22:54:322026-06N021392-004AB1a50c72e98297…
2026-08-01 22:54:322026-06N021392-005AB1a50c72e98297…
2026-08-01 22:54:322026-06N021392-006AB1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Cardizem LADILTIAZEM HYDROCHLORIDEBausch Health US LLC3e180dc7-c871-4efc-8755-cae882976c8d2025-11-11Warnings, Adverse reactionsExact identifier
application applno (NDA): 021392
application number: NDA021392
ndc (product): 0187-2049
ndc (product): 0187-2048
ndc (product): 0187-2047
ndc (product): 0187-2046
ndc (product): 0187-2050
ndc (product): 0187-2045
Diltiazem HydrochlorideDILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETSOceanside Pharmaceuticals73b3607a-99d0-44d8-92ef-0074684c9d7d2025-04-01Warnings, Adverse reactionsExact identifier
application applno (NDA): 021392
application number: NDA021392
ndc (product): 68682-709
ndc (product): 68682-705
ndc (product): 68682-708
ndc (product): 68682-706
ndc (product): 68682-704
ndc (product): 68682-707

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 46 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0187-2045Cardizem LADiltiazem HydrochlorideValeant Pharmaceuticals North America LLCNDACurrent
0187-2045Cardizem LADiltiazem HydrochlorideValeant Pharmaceuticals NNDACurrent
0187-2045Cardizem LADiltiazem HydrochlorideBausch Health US LLCNDACurrent
0187-2045Cardizem LADiltiazem HydrochlorideBausch Health Americas, Inc.NDACurrent
0187-2046Cardizem LADiltiazem HydrochlorideValeant Pharmaceuticals North America LLCNDACurrent
0187-2046Cardizem LADiltiazem HydrochlorideValeant Pharmaceuticals NNDACurrent
0187-2046Cardizem LADiltiazem HydrochlorideBausch Health US LLCNDACurrent
0187-2046Cardizem LADiltiazem HydrochlorideBausch Health Americas, Inc.NDACurrent
0187-2047Cardizem LADiltiazem HydrochlorideValeant Pharmaceuticals North America LLCNDACurrent
0187-2047Cardizem LADiltiazem HydrochlorideValeant Pharmaceuticals NNDACurrent
0187-2047Cardizem LADiltiazem HydrochlorideBausch Health US LLCNDACurrent
0187-2047Cardizem LADiltiazem HydrochlorideBausch Health Americas, Inc.NDACurrent
0187-2048Cardizem LADiltiazem HydrochlorideValeant Pharmaceuticals North America LLCNDACurrent
0187-2048Cardizem LADiltiazem HydrochlorideValeant Pharmaceuticals NNDACurrent
0187-2048Cardizem LADiltiazem HydrochlorideBausch Health US LLCNDACurrent
0187-2048Cardizem LADiltiazem HydrochlorideBausch Health Americas, Inc.NDACurrent
0187-2049Cardizem LADiltiazem HydrochlorideValeant Pharmaceuticals North America LLCNDACurrent
0187-2049Cardizem LADiltiazem HydrochlorideValeant Pharmaceuticals NNDACurrent
0187-2049Cardizem LADiltiazem HydrochlorideBausch Health US LLCNDACurrent
0187-2049Cardizem LADiltiazem HydrochlorideBausch Health Americas, Inc.NDACurrent
0187-2050Cardizem LADiltiazem HydrochlorideValeant Pharmaceuticals North America LLCNDACurrent
0187-2050Cardizem LADiltiazem HydrochlorideValeant Pharmaceuticals NNDACurrent
0187-2050Cardizem LADiltiazem HydrochlorideBausch Health US LLCNDACurrent
0187-2050Cardizem LADiltiazem HydrochlorideBausch Health Americas, Inc.NDACurrent
68682-704Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-704Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-705Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-705Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-705Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-706Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-706Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-706Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-707Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-707Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-707Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-708Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-708Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-708Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-709Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-709Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
68682-709Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsOceanside PharmaceuticalsNDA AUTHORIZED GENERICCurrent
70518-2451Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsREMEDYREPACK INC.NDA AUTHORIZED GENERICCurrent
70518-2451Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsREMEDYREPACK INC.NDA AUTHORIZED GENERICCurrent
70518-2451Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsREMEDYREPACK INC.NDA AUTHORIZED GENERICCurrent
70518-2451Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsREMEDYREPACK INC.NDA AUTHORIZED GENERICCurrent
70518-2451Diltiazem HydrochlorideDiltiazem Hydrochloride Extended-Release TabletsREMEDYREPACK INC.NDA AUTHORIZED GENERICCurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
81965SUPPL 2025-04-24
81964SUPPL 2025-04-24
45917SUPPL2016-11-22
45937SUPPL2016-11-21
15352SUPPL2015-04-14
27649SUPPL2015-03-25
27648SUPPL2010-11-30
36809SUPPL2010-11-22
21631SUPPL2007-07-06
15351SUPPL2007-05-01
5239SUPPL2007-05-01
21630ORIG2005-06-27
27647SUPPL2004-04-07
15350SUPPL2004-04-05
15349ORIG2003-02-06